Registration
PENN AVENUE PARTNERS for FRESENIUS MEDICAL CARE NORTH AMERICA
Firm
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Policy issues related to end stage renal disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY FARRELL HANNEGAN New | U.S. General Accounting Office |
| CHRISTINA MCGARRY DAVID New | Legislative Assistant / Scheduler, Rep. Mario Diaz-Balart |
| JENNIFER YOCHAM POERSCH New | — |
| JERR ROSENBAUM New | Legislative Director, Sen. John Cornyn; Chief of Staff, Rep. Robert Hurt; Chief of Staff, Rep. Jack Kingston; Chief of Staff, Rep. Virgil Goode |
| JAY SULZMANN New | Legislative Director/Health Policy Advisor, Sen. Johnny Isakson; Sr. Policy Advisor/LA/LC/SA, Rep. Wally Herger |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| FRESENIUS SE & CO. KGAA | Germany | Germany | 31.0% | — |
| FRESENIUS MEDICAL CARE AG & CO. KGAA | Germany | Germany | 29.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.